Company news
GT Biopharma, Inc. news in 2024
GT Biopharma, Inc.'s news releases, calls and decks from 2024, newest first.
GT Biopharma Reports Third Quarter 2024 Financial Results
November 13, 2024
GT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024
September 23, 2024
GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 13, 2024
GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia
June 26, 2024
GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
May 20, 2024
GT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 14, 2024
GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results
March 25, 2024
GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split
January 31, 2024